Insulin Resistance and Insulin therapy

Insulin is a peptide hormone produced by the cells of the pancreatic islets of Langerhans that regulates blood glucose levels by aiding cellular glucose uptake, regulating carbohydrate, lipid, and protein metabolism, and encouraging cell division and proliferation through its mitogenic activities. Insulin resistance and its consequences are becoming more prominent as obesity and diabetes reach epidemic proportions in the developed world. Insulin resistance is described as a biological response that is diminished by a normal or elevated insulin level; traditionally, this refers to impaired sensitivity to insulin-mediated glucose disposal. Insulin resistance syndrome is a collection of anomalies and physical consequences that are more likely in people who are insulin resistant.

  1. Diagnosing diabetes
  2. Monitoring diabetes

    Related Conference of Insulin Resistance and Insulin therapy

    May 08-09, 2025

    5th European Endocrinology and Diabetes Congress

    Madrid, Spain
    May 19-20, 2025

    6th World Summit on Diabetes

    Rome, Italy
    June 04-05, 2025

    4th World Congress on Diabetes and Pediatric Endocrinology

    Edinburgh, Scotland
    July 29-30, 2025

    15th World Congress on Endocrinology and Diabetes

    Paris, France
    September 08-09, 2025

    3rd World congress and Expo on Diabetes

    Frankfurt, Germany
    October 30-31, 2025

    5th Annual Summit on Diabetes and Endocrinology

    Paris, France
    November 06-07, 2025

    8th Annual Meeting on Diabetes and Endocrinology

    Dubai, UAE
    November 20-21, 2025

    21st World Congress on Endocrinology & Diabetes

    Paris, France
    March 26-27, 2026

    7th Global summit on Diabetes and Endocrinology

    Amsterdam, Netherlands

    Insulin Resistance and Insulin therapy Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in